432 related articles for article (PubMed ID: 30049651)
21. Six-year clinical outcomes of enzyme replacement therapy for perinatal lethal and infantile hypophosphatasia in Korea: Two case reports.
Kim I; Noh ES; Kim MS; Jang JH; Jeon TY; Choi HW; Cho SY
Medicine (Baltimore); 2023 Feb; 102(6):e32800. PubMed ID: 36820543
[TBL] [Abstract][Full Text] [Related]
22. Relationship between serum alkaline phosphatase and pyridoxal-5'-phosphate levels in hypophosphatasia.
Iqbal SJ; Brain A; Reynolds TM; Penny M; Holland S
Clin Sci (Lond); 1998 Feb; 94(2):203-6. PubMed ID: 9536930
[TBL] [Abstract][Full Text] [Related]
23. Lethal hypophosphatasia successfully treated with enzyme replacement from day 1 after birth.
Okazaki Y; Kitajima H; Mochizuki N; Kitaoka T; Michigami T; Ozono K
Eur J Pediatr; 2016 Mar; 175(3):433-7. PubMed ID: 26459154
[TBL] [Abstract][Full Text] [Related]
24. Markedly increased circulating pyridoxal-5'-phosphate levels in hypophosphatasia. Alkaline phosphatase acts in vitamin B6 metabolism.
Whyte MP; Mahuren JD; Vrabel LA; Coburn SP
J Clin Invest; 1985 Aug; 76(2):752-6. PubMed ID: 4031070
[TBL] [Abstract][Full Text] [Related]
25. Hypophosphatasia in Adults: Clinical Spectrum and Its Association With Genetics and Metabolic Substrates.
Lefever E; Witters P; Gielen E; Vanclooster A; Meersseman W; Morava E; Cassiman D; Laurent MR
J Clin Densitom; 2020; 23(3):340-348. PubMed ID: 30655187
[TBL] [Abstract][Full Text] [Related]
26. Pharmacodynamics of asfotase alfa in adults with pediatric-onset hypophosphatasia.
Seefried L; Kishnani PS; Moseley S; Denker AE; Watsky E; Whyte MP; Dahir KM
Bone; 2021 Jan; 142():115664. PubMed ID: 32987199
[TBL] [Abstract][Full Text] [Related]
27. The value of plasma vitamin B6 profiles in early onset epileptic encephalopathies.
Mathis D; Abela L; Albersen M; Bürer C; Crowther L; Beese K; Hartmann H; Bok LA; Struys E; Papuc SM; Rauch A; Hersberger M; Verhoeven-Duif NM; Plecko B
J Inherit Metab Dis; 2016 Sep; 39(5):733-741. PubMed ID: 27342130
[TBL] [Abstract][Full Text] [Related]
28. Clinical, biochemical and genetic spectrum of low alkaline phosphatase levels in adults.
Riancho-Zarrabeitia L; García-Unzueta M; Tenorio JA; Gómez-Gerique JA; Ruiz Pérez VL; Heath KE; Lapunzina P; Riancho JA
Eur J Intern Med; 2016 Apr; 29():40-5. PubMed ID: 26783040
[TBL] [Abstract][Full Text] [Related]
29. Enzyme-replacement therapy in perinatal hypophosphatasia: Case report and review of the literature.
Rougier H; Desrumaux A; Bouchon N; Wroblewski I; Pin I; Nugues F; Mornet E; Baujat G
Arch Pediatr; 2018 Oct; 25(7):442-447. PubMed ID: 30249491
[TBL] [Abstract][Full Text] [Related]
30. Healthcare resource utilization in the management of hypophosphatasia in three patients displaying a spectrum of manifestations.
Daniel AB; Saraff V; Shaw NJ; Yates R; Mughal MZ; Padidela R
Orphanet J Rare Dis; 2018 Aug; 13(1):142. PubMed ID: 30115096
[TBL] [Abstract][Full Text] [Related]
31. Asfotase Alfa: A Review in Paediatric-Onset Hypophosphatasia.
Scott LJ
Drugs; 2016 Feb; 76(2):255-62. PubMed ID: 26744272
[TBL] [Abstract][Full Text] [Related]
32. Asfotase alfa therapy for children with hypophosphatasia.
Whyte MP; Madson KL; Phillips D; Reeves AL; McAlister WH; Yakimoski A; Mack KE; Hamilton K; Kagan K; Fujita KP; Thompson DD; Moseley S; Odrljin T; Rockman-Greenberg C
JCI Insight; 2016 Jun; 1(9):e85971. PubMed ID: 27699270
[No Abstract] [Full Text] [Related]
33. Evidence for increased catabolism of vitamin B-6 during systemic inflammation.
Ulvik A; Midttun Ø; Pedersen ER; Eussen SJ; Nygård O; Ueland PM
Am J Clin Nutr; 2014 Jul; 100(1):250-5. PubMed ID: 24808485
[TBL] [Abstract][Full Text] [Related]
34. Validated UPLC-MS/MS method for the analysis of vitamin B
Rossmann J; Christ S; Richter S; Friedrich Garbade S; Friedrich Hoffmann G; Opladen T; Günther Okun J
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Dec; 1212():123503. PubMed ID: 36279779
[TBL] [Abstract][Full Text] [Related]
35. Management of perinatal HPP during critical illness/ECMO.
Krishnan N; Dunbar N
J Pediatr Endocrinol Metab; 2022 Jan; 35(1):115-119. PubMed ID: 34582635
[TBL] [Abstract][Full Text] [Related]
36. Clinical, radiographic and biochemical characteristics of adult hypophosphatasia.
Schmidt T; Mussawy H; Rolvien T; Hawellek T; Hubert J; Rüther W; Amling M; Barvencik F
Osteoporos Int; 2017 Sep; 28(9):2653-2662. PubMed ID: 28547134
[TBL] [Abstract][Full Text] [Related]
37. Asfotase Alfa in Perinatal/Infantile-Onset and Juvenile-Onset Hypophosphatasia: A Guide to Its Use in the USA.
Scott LJ
BioDrugs; 2016 Feb; 30(1):41-8. PubMed ID: 26832358
[TBL] [Abstract][Full Text] [Related]
38. Hypophosphatasia: From Diagnosis to Treatment.
Simon S; Resch H; Klaushofer K; Roschger P; Zwerina J; Kocijan R
Curr Rheumatol Rep; 2018 Sep; 20(11):69. PubMed ID: 30203264
[TBL] [Abstract][Full Text] [Related]
39. Hypophosphatasia: Canadian update on diagnosis and management.
Khan AA; Josse R; Kannu P; Villeneuve J; Paul T; Van Uum S; Greenberg CR
Osteoporos Int; 2019 Sep; 30(9):1713-1722. PubMed ID: 30915507
[TBL] [Abstract][Full Text] [Related]
40. Hypophosphatasia: An overview For 2017.
Whyte MP
Bone; 2017 Sep; 102():15-25. PubMed ID: 28238808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
